THE ARISING · Measurement & AI
Your Wearable's Heart Rate Variability May Be Partly Sleep Apnea. A Testable Idea, Rated 45 Percent
Our research desk proposes that the share of nighttime heart rate variability clustered around breathing pauses predicts heart risk beyond the total. Sleep researchers have already shown something close to it, which both supports and narrows the idea.
Higher heart rate variability usually reads as good news on a wearable. But two people with the same nightly number can have very different hearts. Our research desk asks whether when the variability happens, during calm sleep or around breathing pauses, tells you more than how much there is.
Heart rate variability (HRV) measures differences in the time between beats. At rest, more variability often reflects strong parasympathetic control. But obstructive sleep apnea produces its own swings: the heart slows during a breathing pause and races when breathing resumes. Filtering out sensor errors and irregular beats does not remove these real responses.
The desk proposes that the fraction of nighttime variability concentrated around breathing interruptions predicts cardiovascular risk beyond total variability, the number of interruptions and oxygen loss. It also flags a failure mode: if apnea is treated and these swings shrink, an age model that rewards high HRV could report an older age even though breathing improved.
The proposed test uses sleep recordings from the Multi-Ethnic Study of Atherosclerosis (MESA), with cardiovascular follow-up. Success means adding the fraction improves the model's C-index, a measure of how well it ranks people by risk, by at least 0.01. The desk gives this 45 percent, noting that oxygen loss and standard risk factors may already capture most of the signal.
The building blocks are real, and a group at Brigham and Women's Hospital has been working on a very close cousin. In 2021, Azarbarzin and colleagues measured the heart rate surge after apneas and hypopneas, which they called delta-HR, in about 1,400 MESA and 4,600 Sleep Heart Health Study participants.
People with a high surge, compared with a midrange one, had higher risk of nonfatal and fatal cardiovascular disease and of death from any cause. The risk was concentrated in those with a heavy oxygen-loss burden and in people who were not sleepy.
Two 2026 follow-ups extend this. In MESA, apnea with a high heart rate surge or high oxygen burden was associated with a 68 percent higher hazard of new atrial fibrillation. And a pooled analysis of three CPAP trials in European Heart Journal found the treatment's cardiovascular benefit was concentrated in this high-risk group, alongside possible harm in lower-risk patients.
Many readers track HRV and wearable-derived 'biological age.' This idea is a needed caution: a high nighttime HRV is not automatically healthy. Part of it may be apnea. Treating apnea could make the number look worse while your heart is actually under less strain.
Direction is the hard problem, and the desk says so. The 2021 study found U-shaped relationships in MESA: both unusually high and unusually low heart rate responses tracked with worse cardiac markers. A large response can mean strain, while a blunted one can mean an impaired nervous system. A single 'fraction' could blur the two.
Novelty is the other issue. Event-linked heart rate response is already a published risk marker. The new contribution would have to show that a variance-share measure adds something beyond delta-HR, not just beyond total HRV. This is association data; it cannot show that the heart rate swings cause disease.
• Do not read a rising or falling nighttime HRV as proof that your aging has sped up or slowed down. • If you snore loudly, wake unrefreshed, or a partner notices pauses in your breathing, ask your doctor about a sleep study. • If you are diagnosed with apnea, decide on treatment with your clinician based on symptoms and risk, not on what a wearable score does afterward.
• A MESA analysis testing the variability-share measure head to head against delta-HR and oxygen burden. • Whether wearable makers separate apnea-related swings from resting HRV in their age scores. • Prospective trials that select apnea patients for CPAP by heart rate response.
Claim What We Found Tier
Your Wearable's Heart Rate Variability May Be Partly Sleep Apnea. A Testable Idea, Rated 45 Percent AI's Next Race Is Cost per Answer, Not Model Size, and Medicine Will Feel It Staggered Shifts Leave More People Unaware of a Rumour, Our Simulation Suggests